172 related articles for article (PubMed ID: 10903187)
1. Surfactant protein SP-B counteracts inhibition of pulmonary surfactant by serum proteins.
Friedrich W; Schmalisch G; Stevens PA; Wauer RR
Eur J Med Res; 2000 Jul; 5(7):277-82. PubMed ID: 10903187
[TBL] [Abstract][Full Text] [Related]
2. Resistance of different surfactant preparations to inactivation by meconium.
Herting E; Rauprich P; Stichtenoth G; Walter G; Johansson J; Robertson B
Pediatr Res; 2001 Jul; 50(1):44-9. PubMed ID: 11420417
[TBL] [Abstract][Full Text] [Related]
3. Very low surfactant protein C contents in newborn Belgian White and Blue calves with respiratory distress syndrome.
Danlois F; Zaltash S; Johansson J; Robertson B; Haagsman HP; van Eijk M; Beers MF; Rollin F; Ruysschaert JM; Vandenbussche G
Biochem J; 2000 Nov; 351 Pt 3(Pt 3):779-87. PubMed ID: 11042134
[TBL] [Abstract][Full Text] [Related]
4. Biophysical activity of an artificial surfactant containing an analogue of surfactant protein (SP)-C and native SP-B.
Palmblad M; Johansson J; Robertson B; Curstedt T
Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):381-6. PubMed ID: 10191270
[TBL] [Abstract][Full Text] [Related]
5. Antibody to surfactant protein A increases sensitivity of pulmonary surfactant to inactivation by fibrinogen in vivo.
Strayer DS; Herting E; Sun B; Robertson B
Am J Respir Crit Care Med; 1996 Mar; 153(3):1116-22. PubMed ID: 8630554
[TBL] [Abstract][Full Text] [Related]
6. Full length synthetic surfactant proteins, SP-B and SP-C, reduce surfactant inactivation by serum.
Amirkhanian JD; Bruni R; Waring AJ; Navar C; Taeusch HW
Biochim Biophys Acta; 1993 Jul; 1168(3):315-20. PubMed ID: 8323972
[TBL] [Abstract][Full Text] [Related]
7. [A coagulative type of pulmonary surfactant depletion--a mechanism of damage to the pulmonary surfactant system].
Koga Y
Hokkaido Igaku Zasshi; 1994 May; 69(3):434-44. PubMed ID: 7927172
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro.
Cockshutt AM; Weitz J; Possmayer F
Biochemistry; 1990 Sep; 29(36):8424-9. PubMed ID: 2252903
[TBL] [Abstract][Full Text] [Related]
9. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations.
Seeger W; Grube C; Günther A; Schmidt R
Eur Respir J; 1993 Jul; 6(7):971-7. PubMed ID: 8370446
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of pulmonary surfactant and the treatment of acute lung injuries.
Taeusch HW; Keough KM
Pediatr Pathol Mol Med; 2001; 20(6):519-36. PubMed ID: 11699577
[TBL] [Abstract][Full Text] [Related]
11. Differential sensitivity to fibrinogen inhibition of SP-C- vs. SP-B-based surfactants.
Seeger W; Günther A; Thede C
Am J Physiol; 1992 Mar; 262(3 Pt 1):L286-91. PubMed ID: 1550251
[TBL] [Abstract][Full Text] [Related]
12. Protein-lipid interactions and surface activity in the pulmonary surfactant system.
Serrano AG; Pérez-Gil J
Chem Phys Lipids; 2006 Jun; 141(1-2):105-18. PubMed ID: 16600200
[TBL] [Abstract][Full Text] [Related]
13. The role of palmitic acid in pulmonary surfactant: enhancement of surface activity and prevention of inhibition by blood proteins.
Cockshutt AM; Absolom DR; Possmayer F
Biochim Biophys Acta; 1991 Sep; 1085(2):248-56. PubMed ID: 1892895
[TBL] [Abstract][Full Text] [Related]
14. Failure to detect surfactant protein-specific antibodies in sera of premature infants treated with survanta, a modified bovine surfactant.
Whitsett JA; Hull WM; Luse S
Pediatrics; 1991 Apr; 87(4):505-10. PubMed ID: 2011428
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary surfactant protein A interacts with gel-like regions in monolayers of pulmonary surfactant lipid extract.
Worthman LA; Nag K; Rich N; Ruano ML; Casals C; Pérez-Gil J; Keough KM
Biophys J; 2000 Nov; 79(5):2657-66. PubMed ID: 11053138
[TBL] [Abstract][Full Text] [Related]
16. Lipid composition greatly affects the in vitro surface activity of lung surfactant protein mimics.
Seurynck-Servoss SL; Brown NJ; Dohm MT; Wu CW; Barron AE
Colloids Surf B Biointerfaces; 2007 May; 57(1):37-55. PubMed ID: 17287113
[TBL] [Abstract][Full Text] [Related]
17. Experimental neonatal respiratory failure induced by a monoclonal antibody to the hydrophobic surfactant-associated protein SP-B.
Robertson B; Kobayashi T; Ganzuka M; Grossmann G; Li WZ; Suzuki Y
Pediatr Res; 1991 Sep; 30(3):239-43. PubMed ID: 1945561
[TBL] [Abstract][Full Text] [Related]
18. Surfactant protein profile of pulmonary surfactant in premature infants.
Ballard PL; Merrill JD; Godinez RI; Godinez MH; Truog WE; Ballard RA
Am J Respir Crit Care Med; 2003 Nov; 168(9):1123-8. PubMed ID: 12904326
[TBL] [Abstract][Full Text] [Related]
19. Inherited disorders of neonatal lung diseases.
Yurdakök M
Turk J Pediatr; 2004; 46(2):105-14. PubMed ID: 15214737
[TBL] [Abstract][Full Text] [Related]
20. High-yield purification of lung surfactant proteins sp-b and sp-c and the effects on surface activity.
Baatz JE; Zou Y; Cox JT; Wang Z; Notter RH
Protein Expr Purif; 2001 Oct; 23(1):180-90. PubMed ID: 11570861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
